Ikarian Capital »

Lyell Immunopharma shares owned by Ikarian Capital

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $817k 1.3M 0.64
2024-09-30 $726k 526k 1.38
2024-06-30 $763k 526k 1.45

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
venBio Partners
T. Rowe Price Associates
Alphabet
Geode Capital Management
Citadel Advisors
State Street Corporation
OrbiMed Advisors
Sc China Holding
MIC Capital Management UK

View all funds holding Lyell Immunopharma